These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 1982787
1. Peritoneal macrophages from patients on CAPD show an increased capacity to secrete interleukin-1 beta during peritonitis. Fieren MW, van den Bemd GJ, Bonta IL. Adv Perit Dial; 1990; 6():120-2. PubMed ID: 1982787 [Abstract] [Full Text] [Related]
2. Bacterial peritonitis and beta-2 microglobulin (B2M) production by peritoneal macrophages (PM0) in CAPD patients. Carozzi S, Nasini MG, Schelotto C, Caviglia PM, Canepa M, Zanin T, Cantaluppi A, Salit M. Adv Perit Dial; 1990; 6():106-9. PubMed ID: 1982784 [Abstract] [Full Text] [Related]
3. Endotoxin-stimulated peritoneal macrophages obtained from continuous ambulatory peritoneal dialysis patients show an increased capacity to release interleukin-1 beta in vitro during infectious peritonitis. Fieren MW, Van den Bemd GJ, Bonta IL. Eur J Clin Invest; 1990 Aug; 20(4):453-7. PubMed ID: 2121505 [Abstract] [Full Text] [Related]
4. Serial peritoneal macrophage function studies in CAPD patients with peritonitis. Lin CY, Huang TP. Adv Perit Dial; 1990 Aug; 6():114-9. PubMed ID: 1982786 [Abstract] [Full Text] [Related]
5. Interleukin-1 and its naturally occurring antagonist in peritoneal dialysis patients. Moutabarrik A, Nakanishi I, Namiki M, Tsubakihara Y. Clin Nephrol; 1995 Apr; 43(4):243-8. PubMed ID: 7606878 [Abstract] [Full Text] [Related]
6. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis have an increased capability to release tumour necrosis factor during peritonitis. Fieren MW, van den Bemd GJ, Bonta IL, Ben-Efraim S. J Clin Lab Immunol; 1991 Jan; 34(1):1-9. PubMed ID: 1667936 [Abstract] [Full Text] [Related]
7. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta. Fieren MW, van den Bemd GJ, Bonta IL. Prostaglandins Leukot Essent Fatty Acids; 1992 Sep; 47(1):23-8. PubMed ID: 1438464 [Abstract] [Full Text] [Related]
8. Lipopolysaccharide binding protein: a marker for intraperitoneal bacterial infection in patients with CAPD peritonitis. Schäfer K, Schumann RR, Stöteknuel S, Böhler J, Schollmeyer P, Dobos GJ. Adv Perit Dial; 1997 Sep; 13():210-3. PubMed ID: 9360683 [Abstract] [Full Text] [Related]
9. Increased in vitro release of interleukin-1 by LPS stimulated peritoneal macrophages obtained from patients on continuous ambulatory peritoneal dialysis (CAPD) during an infectious peritonitis. Fieren MW, van den Bemd GJ, Bonta IL. Agents Actions; 1990 Jan; 29(1-2):30-1. PubMed ID: 2327316 [No Abstract] [Full Text] [Related]
10. MCP-1 levels are elevated in peritonitis fluid from CAPD patients due to secretion by peritoneal macrophages. Sach M, Loetscher P, Burger JA, Knopf HP, Schollmeyer P, Dobos GJ. Adv Perit Dial; 1995 Jan; 11():19-23. PubMed ID: 8534702 [Abstract] [Full Text] [Related]
12. Reduced secretion of IL-1 beta by peritoneal cells from patients on continuous ambulatory peritoneal dialysis. Hart PH, Jones CA, Jones KL, Finlay-Jones JJ. Immunol Cell Biol; 1993 Apr; 71 ( Pt 2)():99-107. PubMed ID: 8486401 [Abstract] [Full Text] [Related]
13. Peritonitis in continuous ambulatory peritoneal dialysis: cytokines in peritoneal fluid and blood. Enríquez J, Klínger J, Arturo JA, Delgado M, Tobar C, Mosquera M. Adv Perit Dial; 2002 Apr; 18():177-83. PubMed ID: 12402614 [Abstract] [Full Text] [Related]
14. Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. Fieren MW, van den Bemd GJ, Ben-Efraim S, Bonta IL. Immunol Lett; 1992 Jan; 31(1):85-90. PubMed ID: 1548034 [Abstract] [Full Text] [Related]
15. Effect of monophosphoryl lipid A (MPLA) on peritoneal leukocyte function. Carozzi S, Nasini MG, Schelotto C, Caviglia PM, Santoni O, Barocci S, Cantarella S, Versace F, Salit M, Cantaluppi A. Adv Perit Dial; 1989 Jan; 5():143-50. PubMed ID: 2577398 [Abstract] [Full Text] [Related]
16. Cytokines and peritonitis in continuous ambulatory peritoneal dialysis: immunodeviation and immunodeficiency. Klínger J, Enríquez J, Arturo JA, Delgado M, Avila G, Ceballos O. Adv Perit Dial; 2002 Jan; 18():170-6. PubMed ID: 12402613 [Abstract] [Full Text] [Related]
17. Peritoneal dialysis effluent, cytokine levels, and peritoneal mesothelial cell viability in CAPD: a possible relationship. Carozzi S, Nasini MG, Ravera M, Sanna A, Tirotta A, Lamperi S. Adv Perit Dial; 1997 Jan; 13():7-12. PubMed ID: 9360642 [Abstract] [Full Text] [Related]
18. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients. Carozzi S, Nasini G, Schelotto C, Caviglia PM, Canepa M, Zanin T, Cantaluppi A, Salit M. ASAIO Trans; 1990 Jan; 36(3):M369-71. PubMed ID: 2174686 [Abstract] [Full Text] [Related]
19. Advanced glycation end products stimulate tumor necrosis factor-alpha and interleukin-1 beta secretion by peritoneal macrophages in patients on continuous ambulatory peritoneal dialysis. Rashid G, Korzets Z, Bernheim J. Isr Med Assoc J; 2006 Jan; 8(1):36-9. PubMed ID: 16450750 [Abstract] [Full Text] [Related]
20. A low CA++ level in effluent as a risk factor for the peritonitis in CAPD patients. Suga H, Honda H, Naganuma S, Yashuo M, Suzuki T, Teraoka S, Agishi T, Ota K. Adv Perit Dial; 1990 Jan; 6():102-5. PubMed ID: 1982783 [Abstract] [Full Text] [Related] Page: [Next] [New Search]